ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Sharp Therapeutics Corp

Sharp Therapeutics Corp (SHRX)

1,00
-1,10
(-52,38%)
Fermé 19 Juin 10:00PM

Sharp Therapeutics Corp (SHRX) Opérations d'Initiés

-
Filtrer par:
Date Nom du détenteur Actions transigées Fourchette de valeur ($) Type d'opération Fourchette de prix ($) Actions en fin de déclaration % de variation
2025-05-21Mr. Lorne Michael SugarmanIndependent Director & Corporate Secretary40,00k0,00Derivative Acquisition Under Employee Benefit Plan0,77222,50k21,92%
2025-12-17Mr. Edward JonassonCFO225,00k0,00Derivative Acquisition Under Employee Benefit Plan1,16349,50k180,72%
2025-05-21Dr. Dietrich A. StephanINdependent Director40,00k0,00Derivative Acquisition Under Employee Benefit Plan0,77200,84k24,87%
2025-11-03Mr. William R. NewlinIndependent Chairman100,00245,00Achat2,4559,25k0,17%
2025-10-31Mr. William R. NewlinIndependent Chairman2,90k7,11kAchat2,4559,15k5,16%
2025-10-29Mr. William R. NewlinIndependent Chairman2,00k5,22kAchat2,6156,25k3,69%
2025-10-27Mr. William R. NewlinIndependent Chairman1,30k3,39kAchat2,6154,25k2,46%
2025-10-24Mr. William R. NewlinIndependent Chairman500,001,31kAchat2,6152,95k0,95%
2025-10-21Mr. William R. NewlinIndependent Chairman7,20k18,79kAchat2,6152,45k15,91%
2025-10-20Mr. William R. NewlinIndependent Chairman400,001,03kAchat2,56 - 2,6145,25k0,89%
2025-10-16Mr. William R. NewlinIndependent Chairman5,50k12,53kAchat2,10 - 2,5544,85k13,98%
2025-10-17Mr. William R. NewlinIndependent Chairman300,00764,97Achat2,5544,85k0,67%
2025-10-16Mr. William R. NewlinIndependent Chairman100,00190,00Achat1,9042,45k0,24%
2025-10-10Mr. William R. NewlinIndependent Chairman1,50k2,40kAchat1,6038,95k4,01%
2025-10-08Mr. William R. NewlinIndependent Chairman1 000,001,40kAchat1,4037,45k2,74%
2025-10-07Mr. William R. NewlinIndependent Chairman600,00819,00Achat1,04 - 1,4336,45k1,67%
2025-10-03Mr. William R. NewlinIndependent Chairman2,50k886,57Achat0,3535,85k7,50%
2025-08-25Dr. Scott F. SneddonCEO, Chief Science Officer & Director600,00812,23Achat0,53 - 1,52870,85k0,07%